J
Jacobson Pharma Corporation Ltd
HKEX:2633
Jacobson Pharma Corporation Ltd
HKEX:2633
Price:
1.23
HKD
-1.6%
Market Closed
Market Cap:
HK$2.5B
Cash Flow Statement
Cash Flow Statement
Jacobson Pharma Corporation Ltd
Jacobson Pharma Corporation Ltd
Currency: HKD
| Mar-2017 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
221
|
0
|
251
|
0
|
315
|
0
|
263
|
0
|
221
|
0
|
231
|
0
|
340
|
0
|
255
|
0
|
|
| Depreciation & Amortization |
82
|
0
|
112
|
0
|
116
|
0
|
166
|
0
|
192
|
0
|
193
|
0
|
184
|
0
|
157
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
10
|
0
|
5
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
13
|
0
|
|
| Other Non-Cash Items |
5
|
0
|
38
|
0
|
33
|
0
|
51
|
0
|
25
|
0
|
17
|
0
|
67
|
0
|
144
|
0
|
|
| Cash Taxes Paid |
39
|
40
|
56
|
55
|
36
|
36
|
67
|
70
|
27
|
32
|
34
|
33
|
48
|
53
|
57
|
57
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Change in Working Capital |
(145)
|
190
|
(159)
|
326
|
(69)
|
444
|
(119)
|
335
|
(28)
|
490
|
(34)
|
403
|
39
|
598
|
(71)
|
(70)
|
|
| Cash from Operating Activities |
164
N/A
|
190
+16%
|
243
+28%
|
326
+34%
|
396
+22%
|
444
+12%
|
361
-19%
|
335
-7%
|
409
+22%
|
490
+20%
|
407
-17%
|
403
-1%
|
630
+56%
|
598
-5%
|
484
-19%
|
485
+0%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(92)
|
(137)
|
(87)
|
(160)
|
(44)
|
79
|
(84)
|
(78)
|
(63)
|
(63)
|
(64)
|
(39)
|
(63)
|
(113)
|
(130)
|
(152)
|
|
| Other Items |
(714)
|
(758)
|
(242)
|
(354)
|
(583)
|
(583)
|
(353)
|
(409)
|
(310)
|
(47)
|
14
|
(40)
|
(72)
|
60
|
173
|
44
|
|
| Cash from Investing Activities |
(806)
N/A
|
(895)
-11%
|
(328)
+63%
|
(514)
-57%
|
(627)
-22%
|
(504)
+20%
|
(438)
+13%
|
(487)
-11%
|
(373)
+23%
|
(110)
+70%
|
(50)
+55%
|
(79)
-58%
|
(135)
-71%
|
(53)
+61%
|
43
N/A
|
(107)
N/A
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
755
|
0
|
0
|
412
|
412
|
0
|
(151)
|
(129)
|
95
|
97
|
0
|
(23)
|
(32)
|
(10)
|
31
|
0
|
|
| Net Issuance of Debt |
495
|
304
|
466
|
369
|
(74)
|
131
|
167
|
44
|
(25)
|
(281)
|
(280)
|
117
|
172
|
(126)
|
(758)
|
(668)
|
|
| Cash Paid for Dividends |
(239)
|
(40)
|
(42)
|
(75)
|
(89)
|
(90)
|
(100)
|
(40)
|
(63)
|
0
|
(52)
|
0
|
(104)
|
(302)
|
(246)
|
0
|
|
| Other |
(91)
|
724
|
(42)
|
(52)
|
(43)
|
(53)
|
(49)
|
40
|
14
|
(77)
|
(27)
|
(42)
|
(72)
|
(97)
|
(81)
|
(49)
|
|
| Cash from Financing Activities |
919
N/A
|
331
-64%
|
382
+15%
|
654
+71%
|
206
-68%
|
(13)
N/A
|
(133)
-953%
|
(85)
+36%
|
21
N/A
|
(324)
N/A
|
(358)
-10%
|
1
N/A
|
(37)
N/A
|
(534)
-1 360%
|
(1 053)
-97%
|
(734)
+30%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
1
|
(0)
|
(2)
|
(0)
|
1
|
(1)
|
2
|
2
|
(1)
|
(2)
|
(1)
|
(0)
|
1
|
1
|
|
| Net Change in Cash |
277
N/A
|
(373)
N/A
|
297
N/A
|
465
+57%
|
(27)
N/A
|
(73)
-172%
|
(208)
-185%
|
(239)
-15%
|
59
N/A
|
58
-2%
|
(2)
N/A
|
323
N/A
|
458
+42%
|
11
-98%
|
(524)
N/A
|
(355)
+32%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
71
N/A
|
53
-26%
|
156
+195%
|
166
+6%
|
352
+112%
|
523
+49%
|
277
-47%
|
257
-7%
|
346
+35%
|
427
+23%
|
343
-20%
|
364
+6%
|
567
+56%
|
485
-14%
|
355
-27%
|
334
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
